Issues

Mich Law Broken in OMSJ Case?

February 1st, 2012

A Michigan man faces up to eight years in prison in a criminal case marked by confusion, hearsay, and a local health department that might have potentially violated state law.  Holes in this ongoing case of a man alleged to have exposed hundreds of people to HIV suggest that either Kent County or the state — or both – violated policies that could have either contributed to the suspect infecting others, or could lead to a wrongful conviction. (more…)

  • The Alchemy of Flow Cytometry

    Since 2009, OMSJ has examined more than 100 criminal, civil and military cases related to testing, diagnosis and treatment of HIV and AIDS.  In the majority of those cases, OMSJ found that clinicians who relied on high patient caseloads to generate revenue routinely use unreliable HIV tests to misdiagnose their patients. (more…)

  • Patient Advocate Exposed as Pharma Shill

    The head of the Centers for Disease Control and Prevention has declared the overdoses from opioid drugs like OxyContin an “epidemic”.   And a growing group of experts doubts that they work for long-term pain.  But the pills continue to have an influential champion in the American Pain Foundation, which describes itself (more…)

  • Hurricane Experts: Forecasts Too Unreliable

    OTTAWA — Two top U.S. hurricane forecasters, famous across Deep South hurricane country, are quitting the practice of making a seasonal forecast in December because it doesn’t work.  William Gray and Phil Klotzbach say a look back shows their past 20 years of forecasts had no predictive value. (more…)

  • MILITARY: NCIS Admits to Spying on Civilian

    San Diego, CA - Government admissions in the civil rights trial of a Southern California woman suing the Naval Criminal Investigative Service for harassment have sparked questions over whether the law enforcement agency overstepped its authority and engaged in domestic spying. (more…)

  • Scientists’ Elusive Goal: Reproducing Study Results

    Two years ago, a group of Boston researchers published a study describing how they had destroyed cancer tumors by targeting a protein called STK33.  Scientists at biotechnology firm Amgen Inc. quickly pounced on the idea and assigned two dozen researchers to try to repeat the experiment with a goal of turning the findings into a drug. (more…)

more>>

AT ISSUE

OMSJ Demands Editors to Depublish Gallo's Reports

TAKE ACTION

KEY ISSUES

MORE